Research suggests that sulforaphane, a bioactive compound derived from cruciferous vegetables like broccoli, may support gut health by modulating inflammation and favorably reshaping the gut microbiome, with particular interest in its potential relevance to conditions like Inflammatory Bowel Disease. The available evidence comes primarily from review articles and animal studies rather than human clinical trials, with findings generally pointing in a supportive direction — notably, one 2025 mouse study found that regular cooked broccoli consumption increased gut microbial capacity to produce sulforaphane and promoted growth of health-associated bacterial species regardless of obesity status. Studies also indicate that the gut microbiome itself plays a role in converting glucosinolate precursors into sulforaphane, meaning an individual's microbial composition may influence how much benefit they actually derive from dietary sources. It is worth noting that the current body of evidence relies heavily on preclinical and theoretical work, and well-designed human randomized controlled trials are needed before stronger conclusions can be drawn about sulforaphane's role in gut health outcomes.
Citations from PubMed and preprint sources. Match score (0-100) reflects automated search ranking, not clinical appraisal.
| Title | Type | Year | Direction | Match |
|---|---|---|---|---|
| Interplay of broccoli/broccoli sprout bioactives with gut microbiota in reduc... | Review | 2023 | Supports | 100 |
| Promotion of Healthy Aging Through the Nexus of Gut Microbiota and Dietary Ph... | Review | 2025 | Supports | 95 |
| Cooked Broccoli Alters Cecal Microbiota and Impacts Microbial Metabolism of G... | Other | 2025 | Supports | 90 |
| Nrf2 Activator PB125<sup>®</sup>as a Potential Therapeutic Agent Against COVI... | Other | 2020 | Neutral | 85 |